SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving […]
ThredUp to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
OAKLAND, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms […]
Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treatment of Angelman Syndrome
GTX-102 is the first Angelman syndrome therapeutic candidate to receive PRIME designation Phase 1/2 study fully enrolled; expansion data expected […]
Five Tenable Leaders Named 2024 CRN Channel Chiefs
COLUMBIA, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) — Tenable®, the Exposure Management company, today announced that CRN®, a brand of […]
Varonis Announces Fourth Quarter and Full-Year 2023 Financial Results
Annual recurring revenues grew 17% year-over-yearSaaS ARR as a percentage of total ARR was approximately 23%Year-to-date cash from operations generated […]
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
EMERYVILLE, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a leading clinical-stage genetic medicines company […]
Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
AUSTIN, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate […]
Rigetti Computing Wins Innovate UK Competition to Deliver a 24-qubit Quantum Computing System to the National Quantum Computing Centre
LONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Rigetti UK Limited, a wholly owned subsidiary of Rigetti Computing, Inc. (Nasdaq: RGTI) […]
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
BOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing […]
Tactile Medical to Participate in Upcoming Investor Conferences in February and March
MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing […]
